Skip to content

Venn Life Sciences wins new contract worth EUR2.5m

Venn Life Sciences has signed a new contract worth €2.5m with Sedana Medical for a phase III trial. The trial, which is confined to patients in Germany and commences immediately, will confirm the efficacy and safety of sedation with isoflurane in ventilated intensive care patients. Sedana Medical is based in Sweden with operations across Europe, … Continued

Online technology provider Quai Administration wins new contract with Punter Southall Aspire

Punter Southall Aspire appoints online technology provider Quai as administrator for its forthcoming master trust Punter Southall Aspire has selected Quai Administration Services as the out-sourced investment administrator for its forthcoming Master Trust. The firm has also made a strategic investment in Quai, as it continues its approach of taking stakes in service provider partners, … Continued

Premaitha Welcomes UK Govt. Decision

NHS to adopt NIPT for high risk women Manchester, UK – 31 October 2016: Premaitha Health plc (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, welcomes the decision by the UK’s Department of Health to make non-invasive prenatal tests (“NIPT”) routinely available on the NHS to high risk* pregnant women across … Continued

Calculus Capital wins ‘Best EIS Investment Manager’ at the Growth Investor Awards

London, 4th November 2016 Calculus Capital, the private equity fund manager and Enterprise Investment Scheme and VCT specialist, was named Best EIS Investment Manager in the Growth Investor Awards 2016. The awards, which were announced on Thursday 3rd November, recognise the achievements of those enabling ‘scale-up’ businesses to realise their full potential and drive Britain’s … Continued